No registrations found.
ID
Source
Health condition
Complex Regional Pain Syndrome
Pathophysiology
Complex Regionaal Pijnsyndroom
Sponsors and support
Intervention
Outcome measures
Primary outcome
sIL-2R
CRPS severity score as described in Harden, 2017
Secondary outcome
N/A
Background summary
Soluble interleukin-2 receptor levels have been shown to be correlated with disease severity in diseases such as sarcoidosis and rheumatoid arthritis. Recently, this marker has been found to be elevated in Complex Regional Pain Syndrome (CRPS) patients vs healthy controls. In this study we aim to investigate whether an association exists between the level of the sIL-2R in serum of CRPS patients and disease severity.
Study design
Single measurement during visit at outpatient clinic
Intervention
N/A
Inclusion criteria
In order to be eligible to participate in this study, a subject must meet all of the following criteria:
- The subject meets the new IASP clinical diagnostic criteria for CRPS (=diagnosis CRPS).
- Age ≥ 18 years.
- Only one limb is affected.
Exclusion criteria
A potential subject who meets any of the following criteria will be excluded from participation in this study:
- History of an auto-inflammatory or autoimmune disease.
- Current treatment with immunomodulating medication or treatment within the last 6 months.
- Ill in the past two weeks or at the time of the visit.
- Knowledge of or confirmed pregnancy.
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| NTR-new | NL7274 |
| NTR-old | NTR7489 |
| Other | NL66320.078.18 : CCMO |